Aspect Biosystems

aid: aspect-biosystems
name: Aspect Biosystems
description: 'Aspect Biosystems is a Vancouver, British Columbia biotechnology company developing Bioprinted Tissue Therapeutics
  — implantable, allogeneic living tissues designed to replace, repair, or supplement biological function in the body. Spun
  out of an interdisciplinary medicine-and-engineering collaboration at the University of British Columbia in 2013, the company
  operates a self-described full-stack tissue therapeutic platform that integrates proprietary AI-powered microfluidic bioprinting,
  computational tissue design tools, therapeutic and hypoimmune-engineered cells, and advanced biomaterials. Its clinical
  pipeline targets metabolic and endocrine disease, led by pancreatic tissue programs for type 1 diabetes and programs in
  rare endocrine disorders and liver disease. Aspect has raised more than US$350M, including a US$115M Series B, and holds
  partnerships with Novo Nordisk (announced 2023, valued at over US$2.6B in milestones) and the governments of Canada and
  British Columbia. It is a private, pre-commercial therapeutics developer: it publishes no public developer portal, API documentation,
  SDKs, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/aspect-biosystems/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
image: https://aspectbiosystems.com/_images/content/Tamer_Graphic_v5.svg
tags:
- Company
- Biotechnology
- Life Sciences
- Regenerative Medicine
- Bioprinting
- Tissue Engineering
- Cell Therapy
- Healthcare
- Canada
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/aspect-biosystems-domain-security.yml
- type: Website
  url: https://aspectbiosystems.com/
- type: About
  url: https://aspectbiosystems.com/about
- type: Technology
  url: https://aspectbiosystems.com/technology
- type: Contact
  url: https://aspectbiosystems.com/contact
- type: PrivacyPolicy
  url: https://aspectbiosystems.com/privacy-policy
- type: Careers
  url: https://aspectbiosystems.com/careers
- type: News
  url: https://aspectbiosystems.com/news-resources
- type: GitHubOrganization
  url: https://github.com/aspectbiosystems
- type: LinkedIn
  url: https://ca.linkedin.com/company/aspect-biosystems
- type: YouTube
  url: https://www.youtube.com/channel/UC2VA_o9ifVNxAEVoI73j8tA
- type: SecondaryMarket
  url: https://www.hiive.com/securities/aspect-biosystems-stock
- type: LLMsTxt
  url: llms/aspect-biosystems-llms.txt
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
  contract_discovery:
    openapi: none
    swagger: none
    graphql: none
    asyncapi: none
    mcp: none
    agent_card: none
    note: Full contract discovery run 2026-08-02 against aspectbiosystems.com (the only host the company publishes; there
      is no api./docs./developer. subdomain and no baseURL or OpenAPI servers[] host to probe). /openapi.json, /swagger.json,
      /llms.txt, /.well-known/security.txt, /.well-known/openid-configuration, /.well-known/oauth-authorization-server, /.well-known/api-catalog,
      /.well-known/ai-plugin.json, /.well-known/agent-card.json and /.well-known/agent.json all return 404. The complete sitemap.xml
      contains only corporate, technology, programs, partnerships, careers, news and privacy pages — no developer, docs, or
      API section exists. The GitHub organization github.com/aspectbiosystems holds five public repositories, all forks of
      third-party tooling, with no first-party SDK or API implementation. Aspect Biosystems is a pre-commercial clinical-stage
      therapeutics developer with no public API surface. This is a valid completed pass, not a blocked one.